| Title: |
Phase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600–mutant high-grade glioma (HGG) or low-grade glioma (LGG) |
| Authors: |
Hargrave, D.; Witt, O.; Cohen, K.; Packer, R.; Lissat, A.; Kordes, U.; Laetsch, T.W.; Hoffman, L.; Lassaletta, A.; Gerber, N.U.; Gilheeney, S.; Holm, S.; Kramm, C.; Sumerauer, D.; Reitmann, C.; Russo, M.W.; Bouffet, E. |
| Source: |
Annals of Oncology ; volume 29, page viii132 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2018 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/annonc/mdy273.395 |
| Availability: |
http://dx.doi.org/10.1093/annonc/mdy273.395; https://api.elsevier.com/content/article/PII:S0923753419488248?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753419488248?httpAccept=text/plain; http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy273.395/26141277/mdy273.395.pdf |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.494CFEE5 |
| Database: |
BASE |